Life Sciences Tools and Services
Company Overview of Myriad RBM, Inc.
Myriad RBM, Inc., a multiplexed immunoassay testing laboratory, provides protein biomarker services based on its multi-analyte profiling technology platform. It offers reproducible and quantitative multiplexed immunoassay data for various proteins from a single drop of blood serum or plasma to clinical researchers and healthcare providers to advance their drug development and patient care. The company's products and services include Human MAPs that provide insight into various pathways to understand the underlying biology; Rodent MAPs that provide quantitative measurement of biomarkers enabling new pattern discovery, and sensitive safety and efficacy assessments; and Canine KidneyMAP service...
3300 Duval Road
Austin, TX 78759
Founded in 2002
Key Executives for Myriad RBM, Inc.
Managing Director of Communications
Vice President of Corporate Development
Compensation as of Fiscal Year 2014.
Myriad RBM, Inc. Key Developments
Institut Pasteur and Myriad RBM Publish Initial Results from Study of Immune Response
Mar 20 14
Institut Pasteur and Myriad RBM announced they have published an initial data analysis from the Milieu Interieur Project in the journal Immunity, which provided new insights into the healthy human immune response. The Milieu Interieur project is a population-based study supported by the French National Ministry of Research and coordinated by the Institut Pasteur, Paris that will characterize the immune phenotypes of 1,000 healthy subjects. The results could lead to the development of novel diagnostics and companion diagnostics. In the paper titled, 'Functional Analysis using Standardized Whole Blood Stimulation Systems Defines the Boundaries of a Healthy Immune Response to Complex Stimuli,' the authors describe the use of Myriad RBM's TruCulture(r) technology, a proprietary blood collection and culturing system, to characterize individual immune responses of 25 healthy people to medically relevant stimuli. Unlike the current laboratory-based methods, TruCulture is deployed at the site of collection and therefore avoids variability from shipping and complex processing as well as the expense of a cell culture facility and staff. The results in the Immunity paper show that TruCulture stimulations are reproducible, with close correspondence in repeated tests from the same subject.
DVA Laboratory Services, Inc. and Myriad RBM, Inc. Announce Biomarker Research Collaboration
Jun 17 13
DVA Laboratory Services, Inc. and Myriad RBM announced a research collaboration to conduct protein biomarker discovery research with the goal of developing and commercializing diagnostic tests that could benefit in the treatment of dialysis patients. DaVita and Myriad have identified potential opportunities where novel diagnostic tests utilizing blood-based protein biomarkers could improve the quality of life for patients and potentially lower overall healthcare costs. The primary area of focus will include the prediction of vascular access failure.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries